Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
View ORCID ProfileLisa Vermij, View ORCID ProfileJan J. Jobsen, Alicia León-Castillo, View ORCID ProfileMariel Brinkhuis, Suzan Roothaan, View ORCID ProfileMelanie E. Powell, View ORCID ProfileStephanie M. de Boer, View ORCID ProfilePearly Khaw, View ORCID ProfileLinda R. Mileshkin, View ORCID ProfileAnthony Fyles, View ORCID ProfileAlexandra Leary, View ORCID ProfileCatherine Genestie, View ORCID ProfileIna M. Jürgenliemk-Schulz, View ORCID ProfileEmma J. Crosbie, Helen J. Mackay, View ORCID ProfileHans. W. Nijman, View ORCID ProfileRemi A. Nout, View ORCID ProfileVincent T.H.B.M. Smit, View ORCID ProfileCarien L. Creutzberg, View ORCID ProfileNanda Horeweg, View ORCID ProfileTjalling Bosse, TransPORTEC consortium
doi: https://doi.org/10.1101/2022.09.13.22279853
Lisa Vermij
1Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands
M.D.Jan J. Jobsen
2Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, the Netherlands
M.D. Ph.D.Alicia León-Castillo
1Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands
M.D.Mariel Brinkhuis
3Department of Pathology, Laboratorium Pathologie Oost-Nederland, Hengelo, the Netherlands
M.D. PhD.Suzan Roothaan
3Department of Pathology, Laboratorium Pathologie Oost-Nederland, Hengelo, the Netherlands
M.D.Melanie E. Powell
4Department of Clinical Oncology, Barts and The London NHS Trust, London, UK
M.D.Stephanie M. de Boer
5Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands
M.D. Ph.D.Pearly Khaw
6Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
M.D.Linda R. Mileshkin
7Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
M.D.Anthony Fyles
8Department of Radiation Oncology; Princess Margaret Cancer Centre, Toronto, Ontario, Canada
M.D.Alexandra Leary
9Department of Medical Oncology, Gustave Roussy, Villejuif, France
M.D. Ph.D.Catherine Genestie
10Department of Pathology, Gustave Roussy, Villejuif, France
M.D.Ina M. Jürgenliemk-Schulz
11Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands
M.D. Ph.D.Emma J. Crosbie
12Gynaecological Oncology Research Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary’s Hospital, Manchester, UK
13Department of Obstetrics and Gynaecology, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
M.D.Helen J. Mackay
14Department of Medical Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
M.D.Hans. W. Nijman
15Department of Gynaecology, University Medical Center Groningen, Groningen, the Netherlands
M.D.Remi A. Nout
5Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands
M.D.Vincent T.H.B.M. Smit
1Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands
M.D.Carien L. Creutzberg
5Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands
M.D.Nanda Horeweg
5Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands
M.D. Ph.D.Tjalling Bosse
1Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands
M.D. Ph.D.
Posted September 14, 2022.
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
Lisa Vermij, Jan J. Jobsen, Alicia León-Castillo, Mariel Brinkhuis, Suzan Roothaan, Melanie E. Powell, Stephanie M. de Boer, Pearly Khaw, Linda R. Mileshkin, Anthony Fyles, Alexandra Leary, Catherine Genestie, Ina M. Jürgenliemk-Schulz, Emma J. Crosbie, Helen J. Mackay, Hans. W. Nijman, Remi A. Nout, Vincent T.H.B.M. Smit, Carien L. Creutzberg, Nanda Horeweg, Tjalling Bosse, TransPORTEC consortium
medRxiv 2022.09.13.22279853; doi: https://doi.org/10.1101/2022.09.13.22279853
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
Lisa Vermij, Jan J. Jobsen, Alicia León-Castillo, Mariel Brinkhuis, Suzan Roothaan, Melanie E. Powell, Stephanie M. de Boer, Pearly Khaw, Linda R. Mileshkin, Anthony Fyles, Alexandra Leary, Catherine Genestie, Ina M. Jürgenliemk-Schulz, Emma J. Crosbie, Helen J. Mackay, Hans. W. Nijman, Remi A. Nout, Vincent T.H.B.M. Smit, Carien L. Creutzberg, Nanda Horeweg, Tjalling Bosse, TransPORTEC consortium
medRxiv 2022.09.13.22279853; doi: https://doi.org/10.1101/2022.09.13.22279853
Subject Area
Subject Areas
- Addiction Medicine (357)
- Allergy and Immunology (681)
- Anesthesia (182)
- Cardiovascular Medicine (2697)
- Dermatology (231)
- Emergency Medicine (406)
- Epidemiology (12336)
- Forensic Medicine (10)
- Gastroenterology (773)
- Genetic and Genomic Medicine (4181)
- Geriatric Medicine (393)
- Health Economics (690)
- Health Informatics (2704)
- Health Policy (1011)
- Hematology (366)
- HIV/AIDS (865)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3962)
- Nursing (216)
- Nutrition (587)
- Oncology (2090)
- Ophthalmology (597)
- Orthopedics (245)
- Otolaryngology (309)
- Pain Medicine (254)
- Palliative Medicine (76)
- Pathology (474)
- Pediatrics (1136)
- Primary Care Research (464)
- Public and Global Health (6596)
- Radiology and Imaging (1431)
- Respiratory Medicine (879)
- Rheumatology (416)
- Sports Medicine (347)
- Surgery (458)
- Toxicology (56)
- Transplantation (192)
- Urology (170)